Prosecution Insights
Last updated: April 19, 2026

Examiner: INAM, SAHAR

Tech Center 1600 • Art Units: 1622

This examiner grants 100% of resolved cases

Performance Statistics

100.0%
Allow Rate
+40.0% vs TC avg
5
Total Applications
-100.0%
Interview Lift
1175
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
20.0%
§102 Novelty
46.7%
§103 Obviousness
33.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18474204 METHOD FOR ISOMERIZING METHYLTETRAHYDROPHTHALIC ANHYDRIDE Non-Final OA NAN YA PLASTICS CORPORATION
18524124 METHODS OF TREAMENT Non-Final OA Arena Pharmaceuticals, Inc.
18559992 USES AND METHODS FOR RECURRENT PRIMARY CNS NEOPLASMS Non-Final OA CHIMERIX, INC.
18475312 USE OF METHYLAMINOCOLCHICINE AND SALT THEREOF Non-Final OA Shenyang Pharmaceutical University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month